Stem Cell Theranostics secures “freedom to operate” in IP deal with GE Healthcare

Stem Cell Theranostics has secured rights to the technology it uses to make cellular heart disease models for drug development through a deal with GE Healthcare. Stem Cell Theranostics announced the sub-license with GE Healthcare last night, explaining …

[Read the full article here]

Comments are closed.